Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort Study
Open Access
- 24 September 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 57 (12), 1676-1684
- https://doi.org/10.1093/cid/cit655
Abstract
Background. Evidence is limited to guide the management of children exposed to multidrug-resistant (MDR) tuberculosis. We aimed to study the tolerability and toxicity of a standard preventive therapy regimen given to children exposed to infectious MDR tuberculosis, and explore risk factors for poor outcome. Methods. In this prospective cohort study in the Western Cape, South Africa, children Results. One hundred eighty-six children were included, with a median age of 34 months (interquartile range, 14–47 months). Of 179 children tested for HIV, 9 (5.0%) were positive. Adherence was good in 141 (75.8%) children. Only 7 (3.7%) children developed grade 3 adverse events. One child (0.5%) died and 6 (3.2%) developed incident tuberculosis during 219 patient-years of observation time. Factors associated with poor outcome were age P = .009), HIV-positive status (RR, 10.6; 95% CI, 1.01–64.9; P = .049), exposure to multiple source cases (RR, 6.75; 95% CI, 1.11–70.9; P = .036) and poor adherence (RR, 7.50; 95% CI, 1.23–78.7; P = .026). Conclusions. This 3-drug preventive therapy regimen was well tolerated and few children developed tuberculosis or died if adherent to therapy. The provision of preventive therapy to vulnerable children following exposure to MDR tuberculosis should be considered.This publication has 25 references indexed in Scilit:
- The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.The International Journal of Tuberculosis and Lung Disease, 2012
- Management of children exposed to multidrug-resistant Mycobacterium tuberculosisThe Lancet Infectious Diseases, 2012
- Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Paediatric use of second-line anti-tuberculosis agents: A reviewTuberculosis, 2012
- High Incidence of Tuberculosis among HIV‐Infected Infants: Evidence from a South African Population‐Based Study Highlights the Need for Improved Tuberculosis Control StrategiesClinical Infectious Diseases, 2009
- Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research AgendaPLoS Medicine, 2008
- Failure of Chemoprophylaxis With Standard Antituberculosis Agents in Child Contacts of Multidrug-Resistant Tuberculosis CasesThe Pediatric Infectious Disease Journal, 2007
- Cost-Effectiveness of Treating Multidrug-Resistant TuberculosisPLoS Medicine, 2006
- Childhood Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acidsToxicology Letters, 1977